Daily FNArena News - Australia

In a turbulent market, Sigma Healthcare could prove a defensive alternative driven by Chemist Warehouse’s value offering and the company’s international growth

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

Recent court decisions and actions undertaken by ASIC signal a definitive end to corporate complacency regarding regulatory risk in Australia

Analysts discuss the potential impact of the current oil shock on Australia’s banking sector and of increasing AI adoption

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Valuations for contractors and engineering companies are wildly different; a result of investors valuing execution over volume

Despite recent fears around demographic factors weighing on a2 Milk Co’s performance, analysts note supportive Chinese policies and highlight market share gains

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

While ARB Corp’s near-term outlook disappointed with interim results, analysts continue to eye structural industry tailwinds and the US expansion opportunity